ERBB2 and breast cancer: Our scientific journey began with studies of trastuzumab-conjugated AuNPs for X-ray therapy (XRT) radiosensitization of human epidermal growth factor receptor-2 (HER2)-positive BC (Chattopadhyay et al. 2010).